METHYL 4-AMINO-3-METHYLISOXAZOLE-5-CARBOXYLATE, 95.0%, 250mg

Methyl 2-fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 1g

5-Bromo-6-fluoro-2-methyl-1,3-benzothiazole, 98%, 250mg

N-[(isopropylamino)carbonyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide, 98.0%, 100g

Potassium {1-[(tert-butoxy)carbonyl]pyrrolidin-3-yl}trifluoroboranuide, 98+%, 250mg

2-(2-(1,3-Dioxolan-2-yl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

4-Thiouracil, 95.0%, 5g

2-(3,5-Dichlorophenoxy)acetic acid, 95+%, 1g

2,3,5,6-Tetrabromo-4-methyl-4-nitro-2,5-cyclohexadien-1-one, 98%, 25g

DIETHYL 2-(((4-(METHOXYCARBONYL)PHENYL)AMINO)METHYLENE)MALONATE, 95.0%, 100mg

4-Amino-2-fluoro-5-methoxybenzoic acid, 95.0%, 10g

Areometer according to Baumé, 10.0 to 20.0 °Bé

Dialysis membrane Spectra/Por® Biotech CE MWCO 50,000, 10 mm, 1 Piece(s)